These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 3828557)
1. On mathematical modeling of critical variables in cancer treatment (goals: better understanding of the past and better planning in the future). Skipper HE Bull Math Biol; 1986; 48(3-4):253-78. PubMed ID: 3828557 [No Abstract] [Full Text] [Related]
2. Evaluating and designing cancer chemotherapy treatment using mathematical models. Birkhead BG; Gregory WM; Slevin ML; Harvey VJ Eur J Cancer Clin Oncol; 1986 Jan; 22(1):3-8. PubMed ID: 3956557 [No Abstract] [Full Text] [Related]
3. Implications of certain cell kinetic and biological parameters for preoperative chemotherapy. Hill BT Recent Results Cancer Res; 1986; 103():41-53. PubMed ID: 3526475 [No Abstract] [Full Text] [Related]
4. The cancer stem cell gamble. Kaiser J Science; 2015 Jan; 347(6219):226-9. PubMed ID: 25593170 [No Abstract] [Full Text] [Related]
5. Therapeutic antibodies against cancer stem cells: a promising approach. Sneha S; Nagare RP; Priya SK; Sidhanth C; Pors K; Ganesan TS Cancer Immunol Immunother; 2017 Nov; 66(11):1383-1398. PubMed ID: 28840297 [TBL] [Abstract][Full Text] [Related]
6. Role of mathematical modeling in protocol formulation in cancer chemotherapy. Coldman AJ; Goldie JH Cancer Treat Rep; 1985 Oct; 69(10):1041-8. PubMed ID: 2412691 [TBL] [Abstract][Full Text] [Related]
7. Strategies to identify or prevent drug resistance in cancer. A panel discussion. McGuire WL; Goldie JH; Salmon SE; Ling V Breast Cancer Res Treat; 1985; 5(3):257-68. PubMed ID: 4027394 [No Abstract] [Full Text] [Related]
8. A stochastic model for the origin and treatment of tumors containing drug-resistant cells. Coldman AJ; Goldie JH Bull Math Biol; 1986; 48(3-4):279-92. PubMed ID: 3828558 [No Abstract] [Full Text] [Related]
9. At the crossroads of cancer stem cells and targeted therapy resistance. Wang A; Qu L; Wang L Cancer Lett; 2017 Jan; 385():87-96. PubMed ID: 27816488 [TBL] [Abstract][Full Text] [Related]
10. A model for tumor response to chemotherapy: an integration of the stem cell and somatic mutation hypotheses. Goldie JH; Coldman AJ Cancer Invest; 1985; 3(6):553-64. PubMed ID: 3910195 [No Abstract] [Full Text] [Related]
11. A mathematical model of the development of drug resistance to cancer chemotherapy. Birkhead BG; Rankin EM; Gallivan S; Dones L; Rubens RD Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1421-7. PubMed ID: 3678329 [TBL] [Abstract][Full Text] [Related]
12. Variation in growth parameters and their effect on the acquisition of drug resistance. Coldman AJ; Goldie JH Prog Clin Biol Res; 1986; 223():103-11. PubMed ID: 3809192 [No Abstract] [Full Text] [Related]
13. A mathematical model of periodically pulsed chemotherapy: tumor recurrence and metastasis in a competitive environment. Panetta JC Bull Math Biol; 1996 May; 58(3):425-47. PubMed ID: 8688836 [TBL] [Abstract][Full Text] [Related]
14. A mathematical model of drug resistance: heterogeneous tumors. Panetta JC Math Biosci; 1998 Jan; 147(1):41-61. PubMed ID: 9401351 [TBL] [Abstract][Full Text] [Related]
15. Mathematical approaches to optimization of cancer chemotherapy. Zietz S; Nicolini C Bull Math Biol; 1979; 41(3):305-24. PubMed ID: 465827 [No Abstract] [Full Text] [Related]
16. Properties of antileukaemic drugs. Brusamolino E Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():30-3. PubMed ID: 2653515 [No Abstract] [Full Text] [Related]
17. An outlier theory of cancer curability. Tumor cell differentiation as a therapeutic goal. Seifter EJ; Levitt ML; Kramer BS Am J Med; 1987 Oct; 83(4):757-60. PubMed ID: 3674061 [TBL] [Abstract][Full Text] [Related]
18. [Tumor stem cells and their impact on the concept of cancer treatment]. Lu SX Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):81-3. PubMed ID: 20403234 [No Abstract] [Full Text] [Related]